1. Aguilar J, Motato Y, Escriba MJ, Ojeda M, Munoz E, Meseguer M (2014) The human first cell cycle: impact on implantation. RBMOnline 28(4):475–484
2. Albuquerque LE, Tso LO, Saconato H, Albuquerque MC, Macedo CR (2013) Depot versus daily administration of gonadotrophin-releasing hormone agonist protocols for pituitary down regulation in assisted reproduction cycles (Jan 31). Cochrane Database Syst Rev 1:CD002808
3. Al-Inany HG, Youssel MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J (2011) Abou-Setta AM. Hum Reprod Update 17(4):435
4. Alviggi C, Humaidan P, Ezcurra D (2012) Hormonal, functional and genetic biomarkers in controlled ovarian stimulation: tools for matching patients and protocols. RBE 10:9
5. Anifandis G, Michopoulos A, Daponte A, Chatzimeletiou K, Simopoulou M, Messini CI, Polyzos NP, Vassiou K, Dafopoulos K, Goulis DG (2019) Artificial oocyte activation: physiological, pathophysiological and ethical aspects (Feb). Syst Biol Reprod Med 65(1):3–11